Jun 24, 2016 at 11:17 | Source: CNBC-TV18
I wont be surprised to see pharma as the story for July series and wont be surprised in seeing a big upsurge in all big pharma, said SP Tulsian.
Jun 23, 2016 at 16:20 | Source: CNBC-TV18
SP Tulsian of sptulsian.com recommends going long in Lupin, Glenmark Pharma, Aurobindo Pharma and Strides Shasun.
Jun 17, 2016 at 18:17 | Source: CNBC-TV18
SP Tulsian of sptulsian.com recommends profit-booking for anyone holding non-F&O PSU bank stocks at current levels. Also, he gives his views on the HDFC Standard Life and Max Life Insurance merger and sugar stocks.
May 27, 2016 at 22:02 | Source: CNBC-TV18
In an interview with CNBC-TV18, market expert SP Tulsian gave his stock picks for the day and the implication of the Fair and Remunerative Price (FRP) on sugar company's.
May 18, 2016 at 15:28 | Source: PTI
The proposal of Axis Bank to increase foreign investment by FIIs, NRIs, FPIs, ADRs or GDRs from 62 per cent to 74 per cent on a fully fungible basis was cleared by the FIPB in its April 29 meeting.
May 06, 2016 at 13:49 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Union Bank, Karnataka Bank and Havells India.
Apr 30, 2016 at 13:06 | Source: CNBC-TV18
HDFC | Axis Bank | InterGlobe Aviation | IDFC | Oberoi Realty | Cholamandalam Investment | Astra Microwave | Linde India | GIC Housing | Tinplate | Zee Media | Winsome Diamonds | GMR Infrastructure | Elgi Equipment | YES Bank and Rama Steel Tube are stocks, which will be in the news on May 2.
Apr 18, 2016 at 14:22 | Source: PTI
FIPB, chaired by Economic Affairs Secretary Shaktikanta Das, will also consider the proposal of Aurobindo Pharma, One97 Communications, Advanced Enzyme Technologies and Macmillan Publishers International Ltd.
Apr 13, 2016 at 22:17 | Source: CNBC-TV18
In an interview with CNBC-TV18, market analyst SP Tulsian spoke about his outlook on the stock market and discussed stock and sector strategies.
Apr 12, 2016 at 12:45 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com recommends buying Jain Irrigation Systems, midcap pharma, Reliance Capital and Reliance Infrastructure.